You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Metabolic associated fatty liver disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Betweenq MAFLD and Chronic Kidney Disease

Not yet recruiting
  • Mafld in Ckd Patients
    • (no location specified)
    Nov 12, 2023

    Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty

    Not yet recruiting
    • Pancreatic Exocrine Insufficiency
    • FECAL ELASTASE
    • (no location specified)
    Mar 27, 2023

    Fatty Liver Disease, Fatty Liver Trial in Giza (Itopride, conventional therapy)

    Recruiting
    • Fatty Liver Disease
    • Fatty Liver
    • Giza, Egypt
      Maha Youssif Fekry
    Jul 28, 2023

    Metabolic Associated Fatty Liver Disease and Biopsy Proved Cases

    Recruiting
    • Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
      • Asyut, Egypt
      • +1 more
      Nov 27, 2023

      Metabolic Associated Fatty Liver Disease in Chinese Population

      Completed
      • Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 13, 2022

        Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in

        Recruiting
        • Metabolic-associated Fatty Liver Disease (MAFLD)
          • Esik, Almaty Region, Kazakhstan
          • +6 more
          Oct 3, 2023

          Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)

          Recruiting
          • Metabolic Associated Fatty Liver Disease
          • LUDLEV®300 mg/46.2 mg
          • Placebo
          • Mexico, Veracruz, Mexico
            Ana Delfina Cano Contreras
          Jun 12, 2023

          Fatty Liver Disease, Obesity, Liver Fat Trial in Istanbul (Diet, Cornus mas L.(Cornelian Cherry))

          Completed
          • Fatty Liver Disease
          • +2 more
          • Diet
          • Cornus mas L.(Cornelian Cherry)
          • Istanbul, Avcılar, Turkey
            Istanbul Gelisim University
          Sep 16, 2022

          SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

          Not yet recruiting
          • Metabolic Associated Fatty Liver Disease
          • Recombinant protein vaccine and adenovirus vector vaccine
          • (no location specified)
          Feb 12, 2023

          Metabolic Disease, Fatty Liver, Nonalcoholic Trial in Castellana Grotte (Dietary supplementation with fresh oranges, Balanced

          Not yet recruiting
          • Metabolic Disease
          • Fatty Liver, Nonalcoholic
          • Dietary supplementation with fresh oranges
          • Balanced Diet without oranges
          • Castellana Grotte, Bari, Italy
            IRCCS Saverio de Bellis
          Sep 26, 2022

          Metabolic Dysfunction-Associated Fatty Liver Disease, Obesity, Adolescent, Arterial Stiffness Trial in León (L-citrulline,

          Enrolling by invitation
          • Metabolic Dysfunction-Associated Fatty Liver Disease
          • +2 more
          • L-citrulline
          • +2 more
          • León, Guanajuato, Mexico
            Universidad de Guanajuato
          Mar 24, 2023

          Metabolism and Nutrition Disorder, Liver Diseases, Obesity Trial in Shanghai (dietary intervention)

          Not yet recruiting
          • Metabolism and Nutrition Disorder
          • +3 more
          • dietary intervention
          • Shanghai, Shanghai, China
            Department of Clinical Nutrition, Xinhua Hospital Affiliated to
          Jul 1, 2022

          BeijngFH Health Cohort Study

          Recruiting
          • Non-Alcoholic Fatty Liver Disease
            • Beijing, China
              Beijing Friendship Hospital, Capital Medical University
            Sep 18, 2022

            Non-Alcoholic Fatty Liver Disease Trial in Giza (conventional treatment, Furosemide or other alternatives , Niaspan or other

            Recruiting
            • Non-Alcoholic Fatty Liver Disease
            • conventional treatment
            • +2 more
            • Giza, October 6, Egypt
              Maha Youssif Fekry
            Nov 18, 2023

            Metabolic Associated Fatty Liver Disease Trial (dapagliflozin (Forxiga))

            Not yet recruiting
            • Metabolic Associated Fatty Liver Disease
            • dapagliflozin (Forxiga)
            • (no location specified)
            Mar 13, 2023

            Non-Alcoholic Fatty Liver Disease, Hyperuricemia Trial (Allopurinol (100 mg/day) plus lifestyle intervention, Febuxostat 40 mg

            Not yet recruiting
            • Non-Alcoholic Fatty Liver Disease
            • Hyperuricemia
            • Allopurinol (100 mg/day) plus lifestyle intervention
            • +2 more
            • (no location specified)
            Jul 23, 2022

            MAFLD in Type 2 Diabetes in Jiangsu Province of China

            Recruiting
            • Type 2 Diabetes Mellitus in Remission
            • Metabolic Associated Fatty Liver Disease
            • Ultrasound attenuation parameter measurement, fasting blood glucose and fasting insulin determination
            • Nanjing, Jiangsu, China
              Zhongda Hospital, Medical School, Southeast University
            Oct 24, 2022

            Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

            Not yet recruiting
            • Fatty Liver, Nonalcoholic
            • SGLT2 inhibitor
            • (no location specified)
            Oct 31, 2023

            hsCAR and MAFLD: A Cross-sectional Study

            Recruiting
            • Metabolic Dysfunction-associated Fatty Liver Disease
            • +2 more
            • high-sensitivity C-reactive protein to albumin ratio
            • Chongqing, Chongqing, China
              The Second Affiliated Hospital of Chongqing Medical University
            Aug 2, 2023

            Metabolic-associated Fatty Liver Disease, Type 2 Diabetes Trial (Empagliflozin, Dulaglutide, Empagliflozin and Dulaglutide)

            Not yet recruiting
            • Metabolic-associated Fatty Liver Disease
            • Type 2 Diabetes
            • (no location specified)
            Oct 1, 2022

            HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)

            Not yet recruiting
            • HIV
            • +2 more
            • Prebiotic
            • Probiotic
            • Nashville, Tennessee
              Vanderbilt University Medical Center
            Oct 30, 2023

            Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH) Trial

            Enrolling by invitation
            • Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
            • Metabolic Associated-dysfunction Steatohepatitis (MASH)
            • Standard of care acceptance-based behavioral weight loss program
            • Occupational therapy dietary and lifestyle modifications
            • Wyoming, Michigan
              Gastroenterology Associates of Western Michigan, PLC
            Nov 2, 2023

            Fatty Liver Trial in Naples

            Completed
            • Fatty Liver
              • Naples, Italy
                University of Campania Luigi Vanvitelli
              Mar 27, 2023

              CHronic Hepatopathies Associated With ALcohol Consumption aNd

              Not yet recruiting
              • Non-Alcoholic Fatty Liver Disease
              • +4 more
              • Liver biopsy
              • (no location specified)
              Nov 12, 2022

              Fatty Liver Disease Trial in Cheras (Intermittent Fasting)

              Recruiting
              • Fatty Liver Disease
              • Intermittent Fasting
              • Cheras, Kuala Lumpur, Malaysia
                Hospital Canselor Tuanku Muhriz
              May 19, 2023